⌕
Thermo Fisher Scientific · TMO · NYSE
Tenet 42 · Weak
Compare
$686.79−0.66%At closeTenet 42 · Weak
$686.79−4.54 (−0.66%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
$686.00−0.79 (−0.12%)
After hours: Nov 17, 2026, 6:58 PM ET

Thermo Fisher Scientific (TMO) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● Business WireNov 13, 2026 · 16:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will participate in a fireside chat ho…

● Business WireNov 10, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Continues Semiconductor Lab-to-Fab Innovation with Multiple Installations of Optis™ FIB-SEM

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has completed multiple installations of the Thermo Scientific Optis™ focused ion beam-scanning …

● Zacks Investment ResearchNov 9, 2026 · 09:20 ET
Should You Continue to Hold TMO Stock in Your Portfolio?

Thermo Fisher's accelerating organic growth, rising bioproduction demand and strong capital returns support its outlook, but macroeconomic risks and competition remain concerns.…

● BenzingaNov 6, 2026 · 10:21 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings

Thermo Fisher Scientific, Inc. (NYSE:TMO) shares are trading higher by about half a percent on Friday as the company authorized a new share repurchase program and risk appetite is firm, with S&P 500 futures up 1.2%.…

● Seeking AlphaNov 6, 2026 · 09:35 ETEARNINGS EXPECTED BY FEB 1
Diamond Hill Large Cap Fund Q3 2026 Portfolio Update

The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders Fi…

● Business WireNov 5, 2026 · 17:15 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of up to an aggregate of $5 billi…

● Business WireNov 5, 2026 · 17:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share,…

● Business WireNov 5, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduces the Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes. Designed for everyday applicatio…

● Defense WorldNov 4, 2026 · 05:05 ETEARNINGS EXPECTED BY FEB 1
15,095 Thermo Fisher Scientific Inc. $TMO Shares Sold by Bank Julius Baer & Co. Ltd Zurich

Bank Julius Baer and Co. Ltd Zurich cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 65.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,904 shares …

● Defense WorldNov 4, 2026 · 04:25 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Inc. $TMO Shares Newly Bought by Associated Banc Corp

Associated Banc Corp purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commissi…

● Defense WorldNov 3, 2026 · 03:47 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Inc. $TMO Stock: BOCHK Asset Management Ltd Lowers Position

BOCHK Asset Management Ltd reduced its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 8.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission…

● Seeking AlphaOct 27, 2026 · 03:45 ETEARNINGS EXPECTED BY FEB 1
Parnassus Value Equity Fund Q3 2026 Portfolio Review

Parnassus Value Equity Fund (Investor Shares) returned -1.38% (net of fees) for the quarter, underperforming the Russell 1000 Value Index's 2.61%. Top contributors include Thermo Fisher, CME Group, NICE, Willis Towers Wa…

● GuruFocusOct 26, 2026 · 07:22 ET
Is TMO Overvalued? DCF Says Worth $352

On October 26, 2026, we conducted a DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently trading at $673.82. The stock has shown a year-to-d…

● Seeking AlphaOct 26, 2026 · 04:00 ETEARNINGS EXPECTED BY FEB 1
Baron Health Care Fund Q3 2026 Top Contributors And Detractors

TMO's organic growth of 5% exceeded consensus by 200 basis points, and management raised full-year organic growth guidance/. MTD's local-currency sales grew 6%, exceeding prior guidance of 3%. TEVA management raised guid…

● 247 WallstOct 23, 2026 · 07:51 ET
Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More

A wild Thursday saw Treasury yields crater, oil surge past $111, crypto liquidations top $431 million, and Meta's cash flow surprise rattle markets. Now analysts are reshuffling their calls on some of the week's most clo…

● Seeking AlphaOct 21, 2026 · 16:57 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher: You Don't Need A Microscope To See The Growth Anymore

Thermo Fisher Scientific Inc. delivered strong Q3 results, with 6% organic growth, EPS and sales beats, and raised full-year guidance. TMO's growth is driven by robust demand in clinical research, bioproduction, and elec…

● The Motley FoolOct 21, 2026 · 14:42 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific: 3 Key Takeaways for Long-Term Investors

Thermo Fisher raised its 2026 organic revenue growth outlook to 4%. Third-quarter revenue reached $12.14 billion with 6% organic growth.…

● GuruFocusOct 21, 2026 · 13:10 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Stocks Rise 1.0% as Revenue Growth Beats Estimates

Life-sciences tools giant Thermo Fisher Scientific (TMO) reported a strong third quarter Wednesday, with revenue up 9% and adjusted earnings per share up 15%. S…

● BenzingaOct 21, 2026 · 12:13 ETEARNINGS EXPECTED BY FEB 1
Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 1% on Wednesday.…

● Seeking AlphaOct 21, 2026 · 11:34 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript

Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript…

● Zacks Investment ResearchOct 21, 2026 · 10:36 ETEARNINGS EXPECTED BY FEB 1
TMO Q3 Earnings & Revenues Beat Estimates, Stock Down in Pre-Market

Thermo Fisher beats Q3 earnings and revenue estimates, with double-digit profit growth and wider margins, yet shares fall 4.1% in pre-market trading.…

● Zacks Investment ResearchOct 21, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 1
Compared to Estimates, Thermo Fisher (TMO) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates a…

● Seeking AlphaOct 21, 2026 · 10:06 ETEARNINGS EXPECTED BY FEB 1
Thermo Fisher Q3: The Recovery Is Real, And I'm Still Buying

Thermo Fisher Scientific Inc. delivered 6% organic growth, 120 bps margin expansion, and 39% free cash flow growth in Q3, validating the ongoing recovery. I maintain a Strong Buy rating on TMO, supported by accelerating …

● Business WireOct 21, 2026 · 06:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 1
Thermo Fisher Scientific Reports Third Quarter 2026 Results

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2026. Third Quarter Highligh…

● Business WireOct 6, 2026 · 02:00 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026

MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies naviga…

● Business WireOct 5, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associations in PRECISE-SG100K Study

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its strategic collaboration with Precision Health Research, Singapore (PRECISE) and Nanyang Techno…

● Business WireSep 23, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media designed to support strong c…

● Business WireSep 2, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immun…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 1. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA34−0.4%
DLB4−3.8%
EG3−2.0%

Article counts from the last market-wide feed page, across every symbol we track and not just TMO · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.